Literature DB >> 2966834

Survival and cardiac event rates in the first year after emergency coronary angioplasty for acute myocardial infarction.

R S Stack1, R M Califf, T Hinohara, H R Phillips, D B Pryor, C A Simonton, E B Carlson, K G Morris, V S Behar, Y Kong.   

Abstract

One year survival and event-free survival rates were analyzed in 342 patients with acute myocardial infarction who were consecutively enrolled in a treatment protocol of early intravenous thrombolytic therapy followed by emergency coronary angioplasty. Ninety-four percent of the patients achieved successful reperfusion, including 4% with failed angioplasty whose perfusion was maintained by means of a reperfusion catheter before emergency bypass surgery. The procedural mortality rate was 1.2% and the total in-hospital mortality rate was 11%. Ninety-two percent of surviving nonsurgical patients who underwent repeat cardiac catheterization were discharged from the hospital with an open infarct-related artery. The related cumulative 1 year survival rate for all patients managed with this treatment strategy was 87%, and the cardiac event-free survival rate was 84%. The 1 year survival for hospital survivors was 98% and the infarct-free survival rate was 94%. Multivariable analysis identified the following factors as independent predictors of subsequent cardiovascular death: cardiogenic shock, greater age, lower ejection fraction, female gender and a closed infarct-related vessel on the initial coronary angiogram. Among patients with cardiogenic shock, despite a 42% in-hospital mortality rate, only 4% died during the first year after hospital discharge. Similarly, the in-hospital and 1 year postdischarge mortality rates were 19 and 4%, respectively, for patients with an initial ejection fraction less than 40, and 25 and 3%, respectively, for patients greater than 65 years. An aggressive treatment strategy including early thrombolytic therapy, emergency cardiac catheterization, coronary angioplasty and, when necessary, bypass surgery resulted in a high rate of infarct vessel patency.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2966834     DOI: 10.1016/0735-1097(88)90274-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Cardiogenic Shock.

Authors: 
Journal:  Curr Treat Options Cardiovasc Med       Date:  2000-02

2.  Coronary angioplasty in emergency treatment of myocardial infarction in a community-hospital setting.

Authors:  R P Sotolongo; M L Smith; W S Margolis
Journal:  Tex Heart Inst J       Date:  1990

3.  Myocardial protection during surgical intervention for treatment of acute myocardial infarction.

Authors:  F Beyersdorf; G D Buckberg
Journal:  Tex Heart Inst J       Date:  1992

4.  Effectiveness and cost effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients.

Authors:  M Aristides; M Gliksman; N Rajan; P Davey
Journal:  Heart       Date:  1998-01       Impact factor: 5.994

5.  Effects of late reperfusion on infarct expansion and infarct healing in conscious rats.

Authors:  M Morita; S Kawashima; M Ueno; A Kubota; T Iwasaki
Journal:  Am J Pathol       Date:  1993-08       Impact factor: 4.307

6.  After thrombolytic therapy: angiography, angioplasty, or surgery?

Authors:  M L Stadius
Journal:  Tex Heart Inst J       Date:  1990
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.